4,680 Shares in Agilent Technologies, Inc. $A Acquired by West Family Investments Inc.

West Family Investments Inc. bought a new stake in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 4,680 shares of the medical research company’s stock, valued at approximately $622,000.

Other large investors have also recently made changes to their positions in the company. California State Teachers Retirement System lifted its holdings in Agilent Technologies by 12,343.3% during the 2nd quarter. California State Teachers Retirement System now owns 54,577,058 shares of the medical research company’s stock worth $7,249,471,000 after purchasing an additional 54,138,451 shares in the last quarter. State Street Corp lifted its holdings in shares of Agilent Technologies by 1.9% in the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock worth $1,725,611,000 after buying an additional 241,029 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of Agilent Technologies by 2.7% in the second quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock valued at $990,206,000 after acquiring an additional 198,253 shares during the period. Geode Capital Management LLC grew its stake in Agilent Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after acquiring an additional 25,139 shares in the last quarter. Finally, Deutsche Bank AG increased its holdings in Agilent Technologies by 17.1% during the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock worth $930,957,000 after acquiring an additional 1,024,516 shares during the period. 87.41% of the stock is owned by institutional investors.

Agilent Technologies Price Performance

A stock opened at $146.80 on Wednesday. The firm has a 50 day simple moving average of $142.90 and a two-hundred day simple moving average of $128.22. The stock has a market cap of $41.39 billion, a PE ratio of 28.90, a P/E/G ratio of 2.30 and a beta of 1.24. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $163.75. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. During the same quarter last year, the company posted $1.37 EPS. The business’s quarterly revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts predict that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A has been the topic of several recent analyst reports. Morgan Stanley increased their target price on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Piper Sandler assumed coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target for the company. Jefferies Financial Group initiated coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They issued a “hold” rating and a $135.00 price target on the stock. Sanford C. Bernstein increased their price objective on Agilent Technologies from $155.00 to $180.00 and gave the stock an “outperform” rating in a research report on Thursday, August 27th. Finally, HSBC dropped their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $170.33.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.